Current Volume 13(1) 2008 (7)
28 Mar 2008
Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient
Ewa Wątorek, Maria Boratyńska
Ann Transplant 2008; 13(1): 48-52 :: ID: 843644
28 Mar 2008
Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient
Ewa Wątorek, Maria Boratyńska, Agnieszka Hałoń, Marian Klinger
Ann Transplant 2008; 13(1): 48-52 :: ID: 843644
670
28 Mar 2008
BCNU toxicity presenting with a large pericardial and pleural effusion
Ganapathy S. Krishnan, Vijay Chaudhary
Ann Transplant 2008; 13(1): 44-47 :: ID: 843643
28 Mar 2008
BCNU toxicity presenting with a large pericardial and pleural effusion
Ganapathy S. Krishnan, Vijay Chaudhary, Anas Al-Janadi, Jeyanthi Ramanarayanan, Karl J. D’Silva
Ann Transplant 2008; 13(1): 44-47 :: ID: 843643
629
28 Mar 2008
An Attempt To Assess The Influence Of Primary Disease On The Results Of Therapeutic Rehabilitation In An Early Post-Operative Period In Orthotopic Liver Transplant Recipients
Witold Rongies, Sylwia Stępniewska
Ann Transplant 2008; 13(1): 40-43 :: ID: 843642
28 Mar 2008
An Attempt To Assess The Influence Of Primary Disease On The Results Of Therapeutic Rehabilitation In An Early Post-Operative Period In Orthotopic Liver Transplant Recipients
Witold Rongies, Sylwia Stępniewska, Barbara Golińska, Mikołaj Wojtaszek, Włodzimierz Dolecki, Monika Lewandowska, Dariusz Białoszewski, Marek Krawczyk
Ann Transplant 2008; 13(1): 40-43 :: ID: 843642
401
28 Mar 2008
Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients – long term results
Radosław Samsel, Jacek Pliszczyński
Ann Transplant 2008; 13(1): 32-39 :: ID: 843641
28 Mar 2008
Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients – long term results
Radosław Samsel, Jacek Pliszczyński, Andrzej Chmura, Grażyna Korczak, Zbigniew Włodarczyk, Tomasz Cieciura, Beata Lagiewska, Maciej Glyda, Janusz Wyzgal, Leszek Pączek, Magdalena Durlik, Wojciech Rowiński
Ann Transplant 2008; 13(1): 32-39 :: ID: 843641
452
28 Mar 2008
No transmission of porcine endogenous retroviruses (PERVs) in a long-term pig to rat xenotransplantation model and no infection of immunosuppressed rats
Joachim Denner, Volker Specke
Ann Transplant 2008; 13(1): 20-31 :: ID: 843640
28 Mar 2008
No transmission of porcine endogenous retroviruses (PERVs) in a long-term pig to rat xenotransplantation model and no infection of immunosuppressed rats
Joachim Denner, Volker Specke, Alexander Karlas, Irina Chodnevskaja, Thomas Meyer, Vasiliy Moskalenko, Reinhard Kurth, Karin Ulrichs
Ann Transplant 2008; 13(1): 20-31 :: ID: 843640
587
28 Mar 2008
The role of IL-6 during the late phase of liver regeneration
Maria Pachówka, Jolanta Żegarska
Ann Transplant 2008; 13(1): 15-19 :: ID: 843639
28 Mar 2008
The role of IL-6 during the late phase of liver regeneration
Maria Pachówka, Jolanta Żegarska, Rafał Ciecierski, Grażyna Korczak-Kowalska
Ann Transplant 2008; 13(1): 15-19 :: ID: 843639
599
28 Mar 2008
Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature
Behzad Einollahi, Saeed Taheri
Ann Transplant 2008; 13(1): 5-14 :: ID: 843635
28 Mar 2008
Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature
Behzad Einollahi, Saeed Taheri
Ann Transplant 2008; 13(1): 5-14 :: ID: 843635
540
Volume 13(1) 2008 (7) Supplement
01 Jan 2008 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari,
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
256 0
01 Jan 2008 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
256 0
01 Jan 2008 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
262 0
01 Jan 2008 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
262 0
01 Jan 2008 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
281 0
01 Jan 2008 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
281 0
01 Jan 2008 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
282 0
01 Jan 2008 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
282 0
01 Jan 2008 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
312 0
01 Jan 2008 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
312 0
01 Jan 2008 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
263 0
01 Jan 2008 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
263 0
01 Jan 2008 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
264 0
01 Jan 2008 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
264 0
01 Jan 2008 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
250 0
01 Jan 2008 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
250 0
01 Jan 2008 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
276 0
01 Jan 2008 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
276 0
01 Jan 2008 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
258 0
01 Jan 2008 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
258 0
01 Jan 2008 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
286 0
01 Jan 2008 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
286 0
01 Jan 2008 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
272 0
01 Jan 2008 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock, K. Tentschert, A. Griesmacher
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
272 0
01 Jan 2008 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
232 0
01 Jan 2008 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel, M. Outeda MacÃas, I. MartÃn Herranz
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
232 0
01 Jan 2008 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
272 0
01 Jan 2008 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
272 0
01 Jan 2008 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
315 0
01 Jan 2008 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
315 0
01 Jan 2008 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
290 0
01 Jan 2008 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net, H. Ait-Youcef
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
290 0
01 Jan 2008 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
316 0
01 Jan 2008 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
316 0
01 Jan 2008 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
266 0
01 Jan 2008 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
266 0
01 Jan 2008 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
248 0
01 Jan 2008 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
248 0
29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri,
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
252 0
29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
252 0
01 Jan 2008 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
267 0
01 Jan 2008 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
267 0
01 Jan 2008 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
270 0
01 Jan 2008 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
270 0
01 Jan 2008 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
274 0
01 Jan 2008 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
274 0
01 Jan 2008 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
354 0
01 Jan 2008 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
354 0
01 Jan 2008 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
257 0
01 Jan 2008 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
257 0
01 Jan 2008 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre,
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
274 0
01 Jan 2008 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
274 0
01 Jan 2008 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
251 0
01 Jan 2008 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
251 0
01 Jan 2008 :
Generic products – requirements for drug registration
P. K. Kunicki,
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
239 0
01 Jan 2008 :
Generic products – requirements for drug registration
P. K. Kunicki
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
239 0
01 Jan 2008 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq,
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
247 0
01 Jan 2008 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
247 0
01 Jan 2008 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers,
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
262 0
01 Jan 2008 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
262 0
01 Jan 2008 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde,
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
250 0
01 Jan 2008 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
250 0
01 Jan 2008 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud,
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
240 0
01 Jan 2008 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
240 0
01 Jan 2008 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq,
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
247 0
01 Jan 2008 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
247 0
01 Jan 2008 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
271 0
01 Jan 2008 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
271 0
01 Jan 2008 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
245 0
01 Jan 2008 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski, M. D. Pescovitz
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
245 0
01 Jan 2008 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet,
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
296 0
01 Jan 2008 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
296 0
01 Jan 2008 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
228 0
01 Jan 2008 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
228 0
01 Jan 2008 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer,
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
271 0
01 Jan 2008 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
271 0
01 Jan 2008 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka,
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
223 0
01 Jan 2008 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
223 0
01 Jan 2008 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor,
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
432 0
01 Jan 2008 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
432 0
01 Jan 2008 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich,
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
320 0
01 Jan 2008 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
320 0
01 Jan 2008 :
PK/PD modelling of immunosuppressive agents
E. Wyska,
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
324 0
01 Jan 2008 :
PK/PD modelling of immunosuppressive agents
E. Wyska
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
324 0
01 Jan 2008 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee,
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
204 0
01 Jan 2008 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
204 0
01 Jan 2008 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink,
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
341 0
01 Jan 2008 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
341 0
01 Jan 2008 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
283 0
01 Jan 2008 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
283 0
01 Jan 2008 :
Clinical immunosuppression – current status
M. Klinger,
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
308 0
01 Jan 2008 :
Clinical immunosuppression – current status
M. Klinger
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
308 0
01 Jan 2008 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet,
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
286 0
01 Jan 2008 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
286 0
01 Jan 2008 :
Organ transplantation in Poland
M. Durlik,
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
311 0
01 Jan 2008 :
Organ transplantation in Poland
M. Durlik
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
311 0
In Press
07 Mar 2024 : Original article
Outcomes of Renal Transplantation in ANCA-Associated VasculitisAnn Transplant In Press; DOI: 10.12659/AOT.943433
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860